Impulse Monitoring hires Christopher Brown to lead sales:
This article was originally published in Clinica
Christopher Brown has joined Impulse Monitoring (Columbia, Maryland), a provider of intraoperative neuromonitoring services to hospitals, as vice-president of sales. Mr Brown, whose career in the industry spans 18 years, joins from medical staffing firm InteliStaf where he was a vice-president and general manager. Prior to this, he was employed by diversified medtech provider at Steris, where he led surgical and critical care business sales teams covering five regions.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.